The European Investment Bank (EIB) announced on 17 May that it is lending EUR 43 million to Diakonessenhuis hospital in the Netherlands with the support of the European Fund for Strategic Investments (EFSI), the heart of the Investment Plan for Europe, or Juncker Plan. Financing will support the hospital’s strategic investment programme up to 2022, including construction of new facilities and renovation of existing ones. On 17 May, the EIB also signed a EUR 11 million loan agreement with Internet of Things (IoT) security technology company Intrinsic ID to support the expansion of Intrinsic ID’s R&D, engineering, product development and support resources. The EIB gave its in-principle agreement on 15 May to support the financing of Europe’s first home-grown gigafactory for lithium-ion battery cells, Northvolt Ett, in Sweden. Pending finalisation of due diligence and negotiations, the EIB’s financing commitment is expected to be EUR 350 million. On 14 May, Mobidiag Ltd., a commercial stage molecular diagnostics company addressing the spread of infectious diseases and antimicrobial resistance, signed a EUR 25 million growth capital loan with the EIB. Meanwhile, the European Investment Fund (EIF) announced on 13 May that it is guaranteeing EUR 2 billion in innovation loans granted from Bpifrance, while the EIB has provided Banca March with a EUR 70 million guarantee to support Spanish mid-caps and EUR 100 million in financing for Spanish SMEs. The EIB will also lend up to EUR 110 million to Dräger, to fund R&D projects in medical technology targeting life-saving systems such as anaesthesia devices and ventilators.